John Marous
Directeur/Bestuurslid bij Heart Input Output, Inc.
Profiel
John Marous currently works at Heart Input Output, Inc., as Director and Gid Bio Inc., as Director.
Actieve functies van John Marous
Bedrijven | Functie | Begin |
---|---|---|
Heart Input Output, Inc.
Heart Input Output, Inc. Packaged SoftwareTechnology Services Heart Input Output, Inc. provides cloud-based tool using data from electrocardiograms to develop deep learning algorithms focused on individualized predictions through identifying arterial stenosis. It specializes in beat detection, rhythm analysis, disease detection, and Major Adverse Cardiac Events (MACE) risk analysis. The company is headquartered in Pittsburgh, PA. | Directeur/Bestuurslid | - |
Gid Bio Inc.
Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Heart Input Output, Inc.
Heart Input Output, Inc. Packaged SoftwareTechnology Services Heart Input Output, Inc. provides cloud-based tool using data from electrocardiograms to develop deep learning algorithms focused on individualized predictions through identifying arterial stenosis. It specializes in beat detection, rhythm analysis, disease detection, and Major Adverse Cardiac Events (MACE) risk analysis. The company is headquartered in Pittsburgh, PA. | Technology Services |
Gid Bio Inc.
Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | Health Services |